Abstract:Introduction The study aims to explore the utility of BDNF Val66Met polymorphism as a potential biomarker in Indian bipolar disorder patients and its correlation with clinical characteristics. Objectives Genotyping Val66Met in BDNF gene Exploring its association with bipolar disorder (BD). Methods 150 consenting BD patients and matched controls were recruited using a case-control study design. BD severity was assessed using Young's mania rating scale and the Clinical Global Impression - Severity (CGI-S) scale. BDNF Val66Met polymorphism was identified through real-time PCR after DNA extraction. Data was tested for normal distribution. Genotype frequencies between two groups were compared and the Hardy-Weinberg equilibrium assumptions were tested using Chi-Square tests. Clinical-genotypic associations were explored using the Kruskal-Wallis test and confirmed using hierarchical regression. Results Our sample had more males (60%) than females (40%) with mean age of 35.05 years. Most patients had established bipolar disorder and were severely ill (CGI: 38.75, YMRS). Val66Met SNP genotype frequency differed significantly between cases and controls. Val66Val genotype and Val allele were higher in cases. Results consistent with Hardy-Weinberg equilibrium. Table 1. Genotype frequencies of BDNF (rs6265) in cases and controls GENOTYPE CC CT TT CASES 94(62.6%) 47(31.3%) 9(6%) CONTROL 71(47.3%) 69(46%) 10(6.6%) CHI-SQUARE- 7.431 DF(Degree of freedom) - 2 p-value- 0.024 Table 2. Dominant genotype frequencies in cases and controls DOMINANT GENOTYPE CC CT+TT CASES 94(62.6%) 56(37.3%) CONTROLS 71(47.3%) 79(52.6) CHI-SQUARE-7.125 DF(Degree of freedom)-1 p-value-0.007 Table 3. Allelic frequencies of BDNF (rs6265) in BD cases and healthy controls ALLELIC VARIATION C T CASES 235(78.3%) 65(21.6%) CONTROLS 211(70.3%) 89(29.6%) CHI-SQUARE-5.032 DF(Degree of freedom)-1 p-value- 0.024 Conclusions Our study found that Val66Val genotype and Val allele were higher in cases and could be a potential biomarker for bipolar disorder (BD), which is consistent with previous research conducted on the European population. However, further investigations are required to gain a more comprehensive understanding of its impact on BD, including its association with serum BDNF levels, treatment outcomes, and a more diverse study population. Disclosure of Interest None Declared

The BDNF Val66Met polymorphism and health-related quality of life in youth with obesity

Association of BDNF Val66Met polymorphism with both baseline HRQOL scores and improvement in HRQOL scores in Chinese major depressive patients treated with fluoxetine.

Association Of Brain-Derived Neurotrophic Factor Genetic Val66met Polymorphism With Severity Of Depression, Efficacy Of Fluoxetine And Its Side Effects In Chinese Major Depressive Patients

Association Between Brain-Derived Neurotrophic Factor Val66Met Polymorphism and Methamphetamine Use Disorder: A Meta-Analysis

Bdnf Val66met Homozygosity Does Not Influence Plasma Bdnf Levels in Healthy Human Subjects

The BDNF Val66Met polymorphism serves as a potential marker of body weight in patients with psychiatric disorders

Association of the BDNF Val66Met Polymorphism with BMI in Chronic Schizophrenic Patients and Healthy Controls

The BDNF gene Val66Met polymorphism as a modifier of psychiatric disorder susceptibility: progress and controversy

Dosage Effects of BDNF Val66Met Polymorphism on Cortical Surface Area and Functional Connectivity

Comparison of Val66met Polymorphism of BDNF gene in patients of bipolar disorder and healthy controls.

Met carriers of the BDNF Val66Met polymorphism show reduced Glx/NAA in the pregenual ACC in two independent cohorts

BDNF Val66Met Polymorphism and Plasma Levels in Chinese Han Population with Obsessive-Compulsive Disorder and Generalized Anxiety Disorder.

Impact Of Brain-Derived Neurotrophic Factor Val66met Polymorphism On Cortical Thickness And Voxel-Based Morphometry In Healthy Chinese Young Adults

Effect of the BDNF Val66Met Polymorphism on Regional Gray Matter Volumes and Cognitive Function in the Chinese Population.

BDNF Val66Met polymorphism moderates negative symptom expression of bully victimization through resilience in Taiwanese youth

The BDNF Val66Met Polymorphism Does Not Increase Susceptibility to Activity-Based Anorexia in Rats

BDNF Val66Met Polymorphism is Associated with Unstable Angina.

Effects of BDNF Val66Met Polymorphisms on Brain Structures and Behaviors in Adolescents with Conduct Disorder.

Association of BDNF gene polymorphism with bipolar disorders in Han Chinese population.

The brain-derived neurotrophic-factor (BDNF) val66met polymorphism is associated with geriatric depression: a meta-analysis.

Brain-derived neurotrophic factor Val66Met genotype modulates amygdala habituation